SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-020368
Filing Date
2021-05-21
Accepted
2021-05-21 17:20:07
Documents
2
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1591
2 EX-24 DOCUMENT attachment1.htm EX-24 4698
  Complete submission text file 0000899243-21-020368.txt   7828
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CODIAK BIOSCIENCES, INC. 35 CAMBRIDGEPARK DRIVE, SUITE 500 CAMBRIDGE MA 02140
Business Address
Eggimann Anne-Virginie (Reporting) CIK: 0001863371 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39615 | Film No.: 21950260